Guanabenz
From Wikipedia, the free encyclopedia
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
 |
|
|---|---|
 |
|
| Systematic (IUPAC) name | |
| 2-(2,6-dichlorobenzylidene)hydrazinecarboximidamide | |
| Clinical data | |
| AHFS/Drugs.com | Consumer Drug Information |
| MedlinePlus | a686003 |
| Pregnancy cat. | C(US) |
| Legal status | ? |
| Pharmacokinetic data | |
| Protein binding | 90% |
| Half-life | 6 hours |
| Identifiers | |
| CAS number | 5051-62-7 |
| ATC code | None |
| PubChem | CID 5702063 |
| DrugBank | APRD00487 |
| ChemSpider | 4642445  |
| UNII | GGD30112WC |
| KEGG | D04375 |
| ChEMBL | CHEMBL420 |
| Chemical data | |
| Formula | C8H8Cl2N4 |
| Mol. mass | 231.081 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
Guanabenz (pronounced GWAHN-a-benz, sold under the trade name Wytensin) is an alpha agonist of the alpha-2 type that is used as an antihypertensive drug. It is used to treat high blood pressure (hypertension).
The most common side effects during guanabenz therapy are dizziness, drowsiness, dry mouth, headache and weakness.
Guanabenz can make one drowsy or less alert, therefore driving or operating dangerous machinery is not recommended.
|
 |
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
